loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Fosaprepitant Dimeglumine

    Client Email Product
    Menu

    Fosaprepitant Dimeglumine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 20,548Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 22023 / DOSAGE - POWDER;INTRAVENOUS - EQ 150MG BASE/VIAL

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FOSAPREPITANT DIMEGLUMINE(UNII: D35FM8T64X)
    (APREPITANT - UNII:1NF15YR6UY)     		APREPITANT150mg in 5

    Inactive Ingredients

    Ingredient Name
    Athenex Pharmaceutical Division, LLC.
    Lupin Pharmaceuticals, Inc.
    Meitheal Pharmaceuticals Inc.
    Merck Sharp & Dohme Corp.
    Mylan Institutional LLC
    SunGen Pharma, LLC
    ANHYDROUS LACTOSE(3SY5LH9PMK)
    EDETATE DISODIUM(7FLD91C86K)
    hydrochloric acid(QTT17582CB)
    POLYSORBATE 80(6OZP39ZG8H)
    SODIUM HYDROXIDE(55X04QC32I)